Compare Cronos Group Inc (CRON) vs Royal Bank of Canada (RY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cronos Group Inc vs Royal Bank of Canada — how do they compare? Cronos Group Inc trades at $2.74 (market cap $1.02B), while Royal Bank of Canada trades at $215.03 (market cap $294.58B). The key difference: Royal Bank of Canada is far larger — about 288.8× Cronos Group Inc's market cap, and Royal Bank of Canada pays a 2.38% dividend while Cronos Group Inc pays none. Which is the better fit depends on your goals.
| CRON | RY | |
|---|---|---|
Market Cap | $1.02B | $294.58B |
Sector | Health | Financials |
52-Week High | $3.27 | $214.04 |
52-Week Low | $1.95 | $128.46 |
Enterprise Value | $203.29M | — |
Dividend Yield | — | 2.38% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CRON trades at $2.75, showing no change recently. The stock has a mixed technical outlook with a neutral overall signal but bullish moving averages. Fundamentally, revenue grew to $146.59M in 2025, but net income was negative at -$9.45M. Recent news highlights strong Q1 2026 revenue growth of 40% and expansion of its Spinach brand portfolio, though the company faces intense cannabis sector competition.
Outlook is cautious with growth potential from international expansion and market share gains, but profitability remains a challenge. Risks include regulatory uncertainty and competitive pressures. Analyst sentiment is mixed with 60% hold ratings. The stock presents a speculative opportunity for investors betting on continued top-line growth and eventual margin improvement.
Royal Bank of Canada (RY) trades at $210.69, down 0.19% on the day, with a bullish technical signal and consistent earnings beats. The stock shows strong fundamentals with a P/E of 19.45, net income margin of 31.85%, and ROE of 17.17%. Recent Q2 2026 earnings of $2.84 per share exceeded expectations, and the company announced a dividend increase to $1.76 per share alongside a share repurchase program.
RY's outlook is supported by robust profitability and shareholder returns, but risks include a high P/B ratio of 3.21 and macroeconomic sensitivity. Analyst sentiment is mixed with a slight hold bias, yet the stock's technical strength and dividend growth present a compelling case for income-focused investors amid cautious market conditions.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Cronos Group Inc
Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.
Read more on CRON →About Royal Bank of Canada
Royal Bank of Canada is one of the two largest banks in Canada. It is a diversified financial services company, offering personal and commercial banking, wealth-management services, insurance, corporate banking, and capital markets services. The bank is concentrated in Canada, with additional operations in the U.S. and other countries.
Read more on RY →
